Neurology

Top Medical News
Acupuncture eases anxiety in patients with Parkinson’s disease
Yesterday
Acupuncture appears to be beneficial in the treatment of anxiety in patients with Parkinson’s disease, according to a study.
Home-based tDCS a safe, feasible poststroke rehabilitation modality
3 days ago
Remotely supervised transcranial direct current stimulation (tDCS) helps improve cognitive function in stroke survivors, especially those with moderate cognitive decline, according to a study from Korea.
Patients with high-grade glioma are under high levels of distress
3 days ago
Distress levels are high among patients with high-grade gliomas (HGG) and demonstrate high unmet need for distress screening and referral services, a new study has found.
AF increases susceptibility to stroke associated with air pollution exposure
Jairia Dela Cruz, 4 days ago
Atrial fibrillation (AF) exacerbates the effect of air pollution exposure on acute ischaemic stroke outcomes, such that AF patients are more likely to develop stroke when exposed to increasing levels of smog (O3) and carbon monoxide (CO) compared with those who have no AF, according to a Singapore study.
Plasma microRNAs disturbed in Alzheimer’s disease
5 days ago
Patients with Alzheimer’s disease (AD) show slightly dysregulated levels of plasma microRNAs (miRNA), including miRNA-92a-3p and miRNA-29a-3p, a recent study has found.
Tiny implantable cooling device promises drug-free pain relief
Jairia Dela Cruz, 6 days ago
A soft, miniaturized bioresorbable implant that delivers focused, minimally invasive cooling power in living tissues can help alleviate pain on demand without the use of medications and may provide an alternative to opioids and other highly addictive painkillers.
No harms from dementia screening in primary care
27 Sep 2022
Improvements in cardiovascular health (CVH) appear to exert a strong protective effect against dementia in older Asians, reports a recent Korea study.
Special Reports
Product Highlight - Pontevia
16 Mar 2022
Galcanezumab Injection
Shifting paradigms in MS management: Early, optimized interventions improve patient outcomes
04 May 2018
Multiple sclerosis (MS) is one of the most common neurological disorders – affecting over 2.3 million people globally – and it is the leading cause of nontraumatic disability in young adults. However,the availability of supportive resources and services for people with MS is scarce in many regions of the world. In Malaysia, the prevalence of MS is estimated at 2-3/100,000; the current Malaysian clinical practice guidelines on the management of MS recommend disease modifying agents, such as interferon-β and teriflunomide, as first-line therapeutic agents. In this article, Dr Singer - in partnership with Sanofi and the Malaysian Society of Neurosciences - shares his insights into managing MS dynamically, highlighting the importance of early intervention in improving patient outcomes.
Conference Reports
Higher ultra-processed food intake tied to faster cognitive decline
Elaine Soliven, 14 Sep 2022
High consumption of ultra-processed food (UPF) appears to be associated with a rapid decline in cognitive function in adults, according to the ELSA-Brasil* study presented at AAIC 2022.
Hypertensive disorders of pregnancy: A risk factor for dementia?
Roshini Claire Anthony, 05 Sep 2022

Individuals with a history of hypertensive disorders of pregnancy (HDP) appear to have an increased risk of developing dementia, particularly vascular dementia, according to a study presented at AAIC 2022.

ICU admission tied to dementia risk
Roshini Claire Anthony, 30 Aug 2022

Older adults who have been admitted to the intensive care unit (ICU) may have an elevated risk of developing Alzheimer’s dementia or all types of dementia, according to a study presented at AAIC 2022.

Brexpiprazole shows promise in reducing agitation due to Alzheimer’s dementia
Elaine Soliven, 26 Aug 2022
Treatment with brexpiprazole at either 2 or 3 mg significantly reduced agitation compared with placebo in patients with Alzheimer’s dementia, according to the Trial 331-14-213* presented at AAIC 2022.
Dancing protective against AD, dementia?
Audrey Abella, 17 Aug 2022
Studies presented at AAIC 2022 show that dancing could be a protective factor against the development of Alzheimer’s disease (AD) and dementia in older adults.
Subgroup analyses boost masupirdine potential for AD
Audrey Abella, 15 Aug 2022
Post hoc data from a phase II study presented at AAIC 2022 continue to demonstrate the potential of masupirdine (SUVN-502), a selective 5-HT6 receptor antagonist, as a treatment alternative for the management of neuropsychiatric and cognitive symptoms of Alzheimer’s disease (AD).
Two-fold setback: ICU stay doubles dementia risk
Elvira Manzano, 13 Aug 2022
Intensive care unit (ICU) hospitalization doubles the risk of subsequent dementia in older adults, a longitudinal study suggests.
Product Highlights
CME Modules